Senior Consultant Dr. Emily Walden spoke on the American Bar Association (ABA) Healthcare and Pharmaceuticals Committee’s “Intro to Healthcare and Lifesciences for Antirust Practitioners” webinar on 5 March. Dr. Walden and other panelists provided audience members with a broad overview of regulatory overlay, industry economics, and trending antitrust issues in the healthcare and life sciences industry.